SCHEMBL7951797

SCHEMBL7951797

Nc1ccc(OCC(O)CN(Cc2ccccc2)Cc2ccccc2)cc1N

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.59
ALDH1A1 P00352 4/20 0.56
MAPT P10636 2/20 0.56
MAPK1 P28482 2/20 0.56
GAA P10253 1/20 0.56
TSHR P16473 1/20 0.55
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
NPC1 O15118 1/20 0.46
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
KCNH2 Q12809 1/20 0.45
PRMT5 O14744 1/20 0.44
WDR77 Q9BQA1 1/20 0.44
HIF1A Q16665 1/20 0.43
KDM1A O60341 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7951796 1.00 POLB (0.59) POLBALDH1A1MAPTMAPK1GAA
SCHEMBL21759173 0.86 POLB (0.76) POLBALDH1A1MAPTMAPK1GAA
SCHEMBL21759061 0.84 POLB (0.61) POLBALDH1A1MAPTMAPK1GAA
SCHEMBL7962426 0.84 POLB (0.50) POLBALDH1A1MAPTMAPK1GAA
SCHEMBL7962428 0.84 POLB (0.50) POLBALDH1A1MAPTMAPK1GAA
SCHEMBL13866493 0.83 POLB (0.81) POLBALDH1A1MAPTMAPK1GAA
SCHEMBL6027881 0.83 POLB (0.81) POLBALDH1A1MAPTMAPK1GAA
SCHEMBL21759172 0.80 POLB (0.71) POLBALDH1A1MAPTMAPK1GAA
SCHEMBL5884965 0.80 POLB (0.71) POLBALDH1A1MAPTMAPK1GAA
SCHEMBL21759059 0.80 POLB (0.67) POLBALDH1A1MAPTMAPK1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6265581-B1 REACTING SPECIFIED EPOXIDE AND AMINE, REACTING PRODUCT WITH ACID TO FORM ACID ADDITION SALT ELI LILLY AND COMPANY 2001-07-24 US disclosed
US-6093735-A TREATMENT OF TYPE II DIABETES AND OBESITY ELI LILLY AND COMPANY (US) 2000-07-25 US disclosed
US-6075040-A OBESITY AND DIABETES ELI LILLY AND COMPANY (US) 2000-06-13 US disclosed
US-6060492-A SIDE EFFECT REDUCTION ELI LILLY AND COMPANY (US) 2000-05-09 US disclosed
US-5977154-A OBESITY, DIABETES ELI LILLY AND COMPANY (US) 1999-11-02 US disclosed
EP-0764640-A1 Selective beta3 adrenergic agonists ELI LILLY AND COMPANY (US) 1997-03-26 EP disclosed